257 related articles for article (PubMed ID: 18661462)
21. First treatment for serious complications of kidney disease, parathyroid cancer.
FDA Consum; 2004; 38(3):6. PubMed ID: 15218832
[No Abstract] [Full Text] [Related]
22. Role of cinacalcet in management of mineral bone disorder in chronic kidney disease (control of calcium, phosphorus and parathyroid hormone).
Tahara H
Ther Apher Dial; 2008 Oct; 12 Suppl 1():S27-33. PubMed ID: 19032524
[TBL] [Abstract][Full Text] [Related]
23. Cinacalcet HCl: a novel treatment for secondary hyperparathyroidism in stage 5 chronic kidney disease.
Quarles LD
Kidney Int Suppl; 2005 Jul; (96):S24-8. PubMed ID: 15954947
[TBL] [Abstract][Full Text] [Related]
24. Cinacalcet for secondary hyperparathyroidism in hemodialysis recipients.
Owda AK; Alam MG; Kumar J
N Engl J Med; 2004 Jul; 351(2):188-9; author reply 188-9. PubMed ID: 15247361
[No Abstract] [Full Text] [Related]
25. Does cinacalcet safely and effectively maintain long-term PTH control in secondary hyperparathyroidism?
Fukagawa M
Nat Clin Pract Nephrol; 2006 May; 2(5):248-9. PubMed ID: 16932435
[No Abstract] [Full Text] [Related]
26. [Effect of cinacalcet on parathyroid hormone level in hypercalcemic hyperparathyroidism of patients with renal transplantation].
Vaquero E; Esteban de la Rosa RJ; Oliva N; Fernández Castillo R; Fernández Gallegos R; Bravo Soto J
Med Clin (Barc); 2012 Apr; 138(8):323-6. PubMed ID: 21492884
[TBL] [Abstract][Full Text] [Related]
27. [Parathyroid and bone. Calcimimetics and bone metabolism].
Fukumoto S
Clin Calcium; 2007 Dec; 17(12):1865-9. PubMed ID: 18057662
[TBL] [Abstract][Full Text] [Related]
28. [Clinical application of calcimimetics].
Nishi H; Fukagawa M
Clin Calcium; 2004 May; 14(5):756-9. PubMed ID: 15577038
[TBL] [Abstract][Full Text] [Related]
29. Cinacalcet HCl: a calcimimetic agent for the management of primary and secondary hyperparathyroidism.
Franceschini N; Joy MS; Kshirsagar A
Expert Opin Investig Drugs; 2003 Aug; 12(8):1413-21. PubMed ID: 12882626
[TBL] [Abstract][Full Text] [Related]
30. Decreases in parathyroid gland volume after cinacalcet treatment in hemodialysis patients with secondary hyperparathyroidism.
Ichii M; Ishimura E; Okuno S; Chou H; Kato Y; Tsuboniwa N; Nagasue K; Maekawa K; Yamakawa T; Inaba M; Nishizawa Y
Nephron Clin Pract; 2010; 115(3):c195-202. PubMed ID: 20413997
[TBL] [Abstract][Full Text] [Related]
31. Long-term treatment of secondary hyperparathyroidism with the calcimimetic cinacalcet HCl.
Moe SM; Cunningham J; Bommer J; Adler S; Rosansky SJ; Urena-Torres P; Albizem MB; Guo MD; Zani VJ; Goodman WG; Sprague SM
Nephrol Dial Transplant; 2005 Oct; 20(10):2186-93. PubMed ID: 16030053
[TBL] [Abstract][Full Text] [Related]
32. [Basic and clinical aspects of calcimimetics. The clinical effect and usefulness of Cinacalcet as a calcimimetics on three CKD-5D patients undergoing hemodialysis with refractory secondary hyperparathyroidism].
Hanba Y; Ooura M; Negi S; Shigematsu T
Clin Calcium; 2008 Jan; 18(1):81-8. PubMed ID: 18175876
[TBL] [Abstract][Full Text] [Related]
33. Relationship between parathyroid calcium-sensing receptor expression and potency of the calcimimetic, cinacalcet, in suppressing parathyroid hormone secretion in an in vivo murine model of primary hyperparathyroidism.
Kawata T; Imanishi Y; Kobayashi K; Kenko T; Wada M; Ishimura E; Miki T; Nagano N; Inaba M; Arnold A; Nishizawa Y
Eur J Endocrinol; 2005 Oct; 153(4):587-94. PubMed ID: 16189180
[TBL] [Abstract][Full Text] [Related]
34. [Management of secondary hyperparathyroidism].
Cunningham J
Clin Calcium; 2005 Sep; 15 Suppl 1():217-24. PubMed ID: 16279027
[No Abstract] [Full Text] [Related]
35. Cinacalcet: new drug. Secondary hyperparathyroidism: where are the clinical data?
Prescrire Int; 2006 Jun; 15(83):90-3. PubMed ID: 16764095
[TBL] [Abstract][Full Text] [Related]
36. Cinacalcet upregulates calcium-sensing receptors of parathyroid glands in hemodialysis patients.
Sumida K; Nakamura M; Ubara Y; Marui Y; Tanaka K; Takaichi K; Tomikawa S; Inoshita N; Ohashi K
Am J Nephrol; 2013; 37(5):405-12. PubMed ID: 23594726
[TBL] [Abstract][Full Text] [Related]
37. Cinacalcet hydrochloride.
Barman Balfour JA; Scott LJ
Drugs; 2005; 65(2):271-81. PubMed ID: 15631545
[TBL] [Abstract][Full Text] [Related]
38. Clinical utilization of cinacalcet in hypercalcemic conditions.
Messa P; Alfieri C; Brezzi B
Expert Opin Drug Metab Toxicol; 2011 Apr; 7(4):517-28. PubMed ID: 21361849
[TBL] [Abstract][Full Text] [Related]
39. [Calcimimetics, mechanisms of action and therapeutic applications].
Ureña P; Legoupil N; de Vernejoul MC
Presse Med; 2005 Sep; 34(15):1095-100. PubMed ID: 16334889
[TBL] [Abstract][Full Text] [Related]
40. Cinacalcet: benefit and cost.
Cohen E
Nephrol Dial Transplant; 2008 Apr; 23(4):1460; author reply 1460. PubMed ID: 18065795
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
